Ambu A/S (OTCMKTS:AMBBY) Sees Strong Trading Volume - Here's What Happened

Key Points

• Unusually-strong trading volume: About 1,500 shares traded mid-day (a 106% increase from 729), and the stock rose roughly 2% to $10.20 from a $10.00 close.
• Quarterly results: Ambu reported $0.07 EPS on $242.85 million in revenue, with a net margin of 8.86% and return on equity of 9.15%.
• Valuation and technicals: Market cap is $2.40 billion with a P/E of 32.9; the share price is below its 50‑day ($11.88) and 200‑day ($13.49) moving averages, while leverage is low (debt/equity 0.08) and liquidity strong (current ratio 2.86, quick ratio 1.67).

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY - Get Free Report) shares saw unusually-strong trading volume on Thursday . Approximately 1,500 shares were traded during mid-day trading, an increase of 106% from the previous session's volume of 729 shares.The stock last traded at $10.20 and had previously closed at $10.00.

Ambu A/S Stock Up 2.0%

The firm's 50-day moving average price is $11.88 and its 200 day moving average price is $13.49. The firm has a market capitalization of $2.40 billion, a price-to-earnings ratio of 32.90 and a beta of 1.25. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.86 and a quick ratio of 1.67.

Ambu A/S (OTCMKTS:AMBBY - Get Free Report) last announced its earnings results on Wednesday, February 4th. The company reported $0.07 earnings per share (EPS) for the quarter. Ambu A/S had a net margin of 8.86% and a return on equity of 9.15%. The firm had revenue of $242.85 million for the quarter.

Ambu A/S Company Profile

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company's core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu's offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.